Advisor Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $28K | Sell |
4,773
-50
| -1% | -$293 | ﹤0.01% | 3771 |
|
|
2019
Q3 | $37K | Buy |
4,823
+2,882
| +148% | +$22.1K | ﹤0.01% | 3589 |
|
|
2019
Q2 | $27K | Buy |
1,941
+910
| +88% | +$12.7K | ﹤0.01% | 3777 |
|
|
2019
Q1 | $6K | Hold |
1,031
| – | – | ﹤0.01% | 4608 |
|
|
2018
Q4 | $3K | Hold |
1,031
| – | – | ﹤0.01% | 4735 |
|
|
2018
Q3 | $8K | Hold |
1,031
| – | – | ﹤0.01% | 4398 |
|
|
2018
Q2 | $10K | Hold |
1,031
| – | – | ﹤0.01% | 4084 |
|
|
2018
Q1 | $9K | Hold |
1,031
| – | – | ﹤0.01% | 4155 |
|
|
2017
Q4 | $13K | Buy |
1,031
+300
| +41% | +$3.78K | ﹤0.01% | 3949 |
|
|
2017
Q3 | $6K | Sell |
731
-80
| -10% | -$657 | ﹤0.01% | 4218 |
|
|
2017
Q2 | $14K | Sell |
811
-420
| -34% | -$7.25K | ﹤0.01% | 3751 |
|
|
2017
Q1 | $25K | Buy |
1,231
+500
| +68% | +$10.2K | ﹤0.01% | 3237 |
|
|
2016
Q4 | $11K | Buy |
+731
| New | +$11K | ﹤0.01% | 3583 |
|